Clifton C, Niemeyer B, Novak R, Can U, Hainline K, Benam K. BPIFA1 is a secreted biomarker of differentiating human airway epithelium. Front Cell Infect Microbiol. 2022;12:1035566 pubmed publisher

Sanmarco L, Chao C, Wang Y, Kenison J, Li Z, Rone J, et al. Identification of environmental factors that promote intestinal inflammation. Nature. 2022;611:801-809 pubmed publisher

Wu X, Roberto J, Knupp A, Greninger A, Truong C, Hollingshead N, et al. Response of Human Liver Tissue to Innate Immune Stimuli. Front Immunol. 2022;13:811551 pubmed publisher

Nesterenko P, McLaughlin J, Tsai B, Burton Sojo G, Cheng D, Zhao D, et al. HLA-A∗02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses. Cell Rep. 2021;37:110167 pubmed publisher

Dugger D, Calabrese D, Gao Y, Deiter F, Tsao T, Maheshwari J, et al. Lung Allograft Epithelium DNA Methylation Age Is Associated With Graft Chronologic Age and Primary Graft Dysfunction. Front Immunol. 2021;12:704172 pubmed publisher

Lim S, Alavi S, Ming Z, Shklovskaya E, Fung C, Stewart A, et al. Melanoma Cell State-Specific Responses to TNFα. Biomedicines. 2021;9: pubmed publisher

Jongsma M, de Waard A, Raaben M, Zhang T, Cabukusta B, Platzer R, et al. The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses. Immunity. 2021;54:132-150.e9 pubmed publisher

Mo F, Watanabe N, McKenna M, Hicks M, Srinivasan M, Gomes Silva D, et al. Engineered off-the-shelf therapeutic T cells resist host immune rejection. Nat Biotechnol. 2021;39:56-63 pubmed publisher

Kagoya Y, Nakatsugawa M, Saso K, Guo T, Anczurowski M, Wang C, et al. DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models. Nat Commun. 2018;9:1915 pubmed publisher

Wu X, Roberto J, Knupp A, Kenerson H, Truong C, Yuen S, et al. Precision-cut human liver slice cultures as an immunological platform. J Immunol Methods. 2018;455:71-79 pubmed publisher

Garcia Montero A, Jara Acevedo M, Alvarez Twose I, Teodosio C, Sanchez Muñoz L, Muñiz C, et al. KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression. Blood. 2016;127:761-8 pubmed publisher